John R. Corboy

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression

Sean J. Pittock, Brian G. Weinshenker, Claudia F. Lucchinetti et al. · Archives of Neurology · 2006 · 702 citations

Life Sciences, Neurology, Neuroscience +15

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

Timothy R. Vollmer, Lyndon Key, Valerie Durkalski et al. · The Lancet · 2004 · 470 citations

Life Sciences, Neurology, Pharmacotherapy +7

Multiple sclerosis prevalence in the United States commercially insured population

Piyameth Dilokthornsakul, Robert J. Valuck, Kavita Nair et al. · Neurology · 2016 · 278 citations · Full text

Medicine, Insurance, Neurology +12

Factors that influence adherence with disease-modifying therapy in MS

Katherine Treadaway, Gary Cutter, Amber Salter et al. · Journal of Neurology · 2009 · 257 citations

Pharmacy, Pharmacotherapy, Self-management Support +11